\
&
Contact us
\
&
Contact us
Published on | 4 years ago
Programmes Widening/SpreadingThe submission session is now available for: HORIZON-WIDERA-2022-ACCESS-01-01-two-stage(HORIZON-CSA) or the Teaming for Excellence call.
Under the transitional provisions set in the General Annex to the Horizon Europe (HE) Work Programme, a new association agreement needs to be stipulated by each country. However, for the purpose of eligibility conditions, applicants established in Countries associated to H2020 are considered eligible for HE.
For the purpose of the eligibility conditions to this call, the list of Associated Countries eligible for hosting a Widening coordinator is:
Source: Funding and Tenders Portal
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
